Alterity Therapeutics News

Alterity Therapeutics' ATH434 Shows Treatment Promise

TipRanksApr 29 06:58 ET

Alterity Therapeutics Aims for ASX Listing Boost

TipRanksApr 28 21:47 ET

Alterity Therapeutics' Breakthrough in Rare Disease Treatment

TipRanksApr 28 20:58 ET

Alterity Therapeutics Announced Presentation Of New Data Demonstrating Potential Of ATH434 To Treat Rare Neurodegenerative Disease Friedreich's Ataxia

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announc

BenzingaApr 28 20:42 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersCatheter Precision (AMEX:VTAK) shares moved upwards by 27.8% to $0.58 during Wednesday's regular session. The company's market cap stands at $4.4 million. Prenetics Global (NASDAQ:PRE) stock mo

BenzingaApr 24 12:31 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS

BenzingaApr 23 16:31 ET

Alterity Therapeutics Parkinson's Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announc

BenzingaApr 17 07:26 ET

Alterity Therapeutics Showcases Promising Neurodegenerative Drug Data

TipRanksApr 17 06:57 ET

Alterity Therapeutics Expands Securities Quotation

TipRanksApr 15 20:57 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersDynatronics (NASDAQ:DYNT) stock increased by 70.1% to $0.63 during Monday's after-market session. The company's market cap stands at $3.0 million. Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock r

BenzingaApr 15 16:31 ET

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d

BenzingaApr 15 14:11 ET

BSGM, ENLV and WISA Among Mid-day Movers

Seeking AlphaApr 15 12:47 ET

NXPL, MGRM and OCX Among Pre-market Losers

Seeking AlphaApr 15 08:21 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47

BenzingaApr 15 08:07 ET

Alterity Therapeutics Applies for New Options Quotation

TipRanksApr 14 23:07 ET

Alterity Therapeutics Launches Exclusive Options Offer

TipRanksApr 11 22:07 ET

Alterity Therapeutics' Resolutions Pass Unanimously

TipRanksApr 11 21:47 ET

ATUS, ATHE and GRFS Among Pre-market Losers

Seeking AlphaApr 11 08:16 ET

Press Release: Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund

Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (AS

Dow JonesMar 26 10:25 ET

Alterity Therapeutics Secures $3.9M R&D Refund

TipRanksMar 26 08:57 ET